Literature DB >> 7945921

Expression of vimentin in gastric cancer: a possible indicator for prognosis.

K Takemura1, R Hirayama, K Hirokawa, M Inagaki, K Tsujimura, Y Esaki, Y Mishima.   

Abstract

Expression of vimentin in gastric cancer was immunohistologically examined in 85 surgically resected specimens and evaluated in terms of various clinicopathological features. Vimentin expression was more pronounced in gastric cancers of more advanced type and in those exhibiting a higher degree of infiltrative growth, lymph node involvement and vascular invasion. These results indicate that vimentin expression by gastric cancer might be related to the invasion and metastatic process of cancer cells and could be useful as a prognostic indicator for patients with gastric cancer.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7945921     DOI: 10.1159/000163895

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  7 in total

Review 1.  Vimentin in cancer and its potential as a molecular target for cancer therapy.

Authors:  Arun Satelli; Shulin Li
Journal:  Cell Mol Life Sci       Date:  2011-06-03       Impact factor: 9.261

2.  Cowpea mosaic virus nanoparticles target surface vimentin on cancer cells.

Authors:  Nicole F Steinmetz; Choi-Fong Cho; Amber Ablack; John D Lewis; Marianne Manchester
Journal:  Nanomedicine (Lond)       Date:  2011-02       Impact factor: 5.307

3.  Vimentin-positive gastric adenocarcinoma arising in a hyperplastic polyp.

Authors:  Shogo Kawaguchi; Tetsuro Yoshimura; Hirotake Sakuraba; Taka Asari; Yohei Sawada; Yasumitsu Araki; Koji Kikuchi; Toyohito Wada; Tomomi Kusumi; Shinsaku Fukuda
Journal:  Clin J Gastroenterol       Date:  2018-02-07

4.  Vimentin as a potential therapeutic target in sorafenib resistant HepG2, a HCC model cell line.

Authors:  Ankita Makol; Harpreet Kaur; Sakshi Sharma; Shruthi Kanthaje; Ramanpreet Kaur; Anuradha Chakraborti
Journal:  Clin Mol Hepatol       Date:  2019-09-30

Review 5.  Recent Advances in the Development of Antineoplastic Agents Derived from Natural Products.

Authors:  Matthew Trendowski
Journal:  Drugs       Date:  2015-11       Impact factor: 9.546

6.  Changes in the in vitro activity of platinum drugs when administered in two aliquots.

Authors:  Zaynab Al-Eisawi; Philip Beale; Charles Chan; Jun Qing Yu; Nicholas Proschogo; Mark Molloy; Fazlul Huq
Journal:  BMC Cancer       Date:  2016-08-26       Impact factor: 4.430

Review 7.  Vimentin Diversity in Health and Disease.

Authors:  Frida Danielsson; McKenzie Kirsten Peterson; Helena Caldeira Araújo; Franziska Lautenschläger; Annica Karin Britt Gad
Journal:  Cells       Date:  2018-09-21       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.